ClinVar Miner

Submissions for variant NM_032608.7(MYO18B):c.2135G>A (p.Arg712His)

gnomAD frequency: 0.00001  dbSNP: rs772067339
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001995366 SCV002254077 uncertain significance not provided 2022-08-09 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 712 of the MYO18B protein (p.Arg712His). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with MYO18B-related conditions. ClinVar contains an entry for this variant (Variation ID: 1471023). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV003224600 SCV003920258 uncertain significance Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome 2021-03-30 criteria provided, single submitter clinical testing MYO18B NM_001318245.2 exon 9 p.Arg712His (c.2135G>A): This variant has not been reported in the literature but is present in 0.003% (9/232204) of total alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/22-26176089-G-A). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
Ambry Genetics RCV003355717 SCV004073589 uncertain significance Inborn genetic diseases 2023-08-21 criteria provided, single submitter clinical testing The c.2135G>A (p.R712H) alteration is located in exon 9 (coding exon 8) of the MYO18B gene. This alteration results from a G to A substitution at nucleotide position 2135, causing the arginine (R) at amino acid position 712 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.